药物信息为HALDOL Decanoate 50 (haloperidol) HALDOL Decanoate 100 (haloperidol) (Ortho-McNeil-Janssen Pharmaceuticals, Inc.): CONTRAINDICATIONS
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- PRINCIPAL DISPLAY PANEL - 50 mg/mL label
- PRINCIPAL DISPLAY PANEL- 50 mg/mL box
- 外部链接相关的HALDOL Decanoate 50 (haloperidol) HALDOL Decanoate 100 (haloperidol) (Ortho-McNeil-Janssen Pharmaceuticals, Inc.)
Since the pharmacologic and clinical actions of HALDOL Decanoate 50 and HALDOL Decanoate 100 are attributed to HALDOL (haloperidol) as the active medication, Contraindications, Warnings, and additional information are those of HALDOL, modified only to reflect the prolonged action.
HALDOL is contraindicated in severe toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this drug or have Parkinson's disease.
- Drug Information Provided by National Library of Medicine (NLM).
